LEADER 01300nam  2200385Ka 450 
001 9910696179703321
005 20070907092235.0
035   $a(CKB)5470000002375011
035   $a(OCoLC)169873256
035   $a(EXLCZ)995470000002375011
100   $a20070907d2002      ua             0
101 0 $aeng
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aFDA's center on the front line of the biomedical frontier$b[electronic resource]
205   $aRev. Feb. 2002.
210  1$aRockville, MD :$cDept. of Health and Human Services, Food and Drug Administration, Office of Public Affairs,$d[2002]
215   $a1 sheet $cdigital, PDF file
225 1 $aJust the facts
225 1 $aPublication ;$vno. FS 01-4
300   $aTitle from title screen (viewed Sept. 6, 2007)
606   $aMolecular biology$xResearch
606   $aBiotechnology
606   $aBioterrorism
615  0$aMolecular biology$xResearch.
615  0$aBiotechnology.
615  0$aBioterrorism.
712 02$aUnited States.$bFood and Drug Administration.$bOffice of Public Affairs.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910696179703321
996   $aFDA's center on the front line of the biomedical frontier$93161062
997   $aUNINA